Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › High-dose statins for age-related macular degeneration

High-dose statins for age-related macular degeneration

US Patent 11331295 · Granted May 17, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified Mullerian Inhibiting Substance (MIS) proteins and uses thereof for the 2025
Biomarkers for age-related macular degeneration2023
High-dose statins for age-related macular degeneration2023
High-dose statins for age-related macular degeneration2023
Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the 2021
Methods for treating ocular inflammatory disorders2020
Methods for treating ocular inflammatory disorders2020
Methods for treating diabetic neurotherapy2020
Methods for treating diabetic neurotherapy2020
Compositions for preserving photoreceptor cells, retinal pigment epithelial cell2020
Compositions for preserving photoreceptor cells, retinal pigment epithelial cell2020
Methods and compositions for preserving retinal ganglion cells2020